BACKGROUND:Chronic suppurative otitis media (CSOM) affects many children in disadvantaged populations. The most appropriate topical antibiotic treatment in children with persistent disease is unclear. METHODS:Children with CSOM despite standard topical treatment were randomized to 6-8 weeks of topical ciprofloxacin (CIP) versus topical framycetin-gramicidin-dexamethasone (FGD). Otoscopic, audiologic, and microbiologic outcomes were measured using standardized assessments and blinding. RESULTS:Ninety-seven children were randomized. Ear discharge failed to resolve at the end of therapy in 70% children regardless of allocation [risk difference = -2%; (95% CI: -20 to 16)]. Healing of the tympanic membrane occurred in one of 50 children in the CIP group and none of 47 children in the FGD group. Severity of discharge failed to improve in more than 50% children in each group, and mean hearing threshold (38 dB and 35 dB) and proportion of children with greater than 25 dB hearing loss (98% and 88%) were not significantly different between the CIP and FGD groups. Side effects were rare. CONCLUSIONS: This study showed a similarly low rate of improvement or cure in children with persistent CSOM for both CIP and FGD topical therapies. Complications and side effects were insufficient to cease therapy or inform prescribing of either therapy.
RCT Entities:
BACKGROUND: Chronic suppurative otitis media (CSOM) affects many children in disadvantaged populations. The most appropriate topical antibiotic treatment in children with persistent disease is unclear. METHODS:Children with CSOM despite standard topical treatment were randomized to 6-8 weeks of topical ciprofloxacin (CIP) versus topical framycetin-gramicidin-dexamethasone (FGD). Otoscopic, audiologic, and microbiologic outcomes were measured using standardized assessments and blinding. RESULTS: Ninety-seven children were randomized. Ear discharge failed to resolve at the end of therapy in 70% children regardless of allocation [risk difference = -2%; (95% CI: -20 to 16)]. Healing of the tympanic membrane occurred in one of 50 children in the CIP group and none of 47 children in the FGD group. Severity of discharge failed to improve in more than 50% children in each group, and mean hearing threshold (38 dB and 35 dB) and proportion of children with greater than 25 dB hearing loss (98% and 88%) were not significantly different between the CIP and FGD groups. Side effects were rare. CONCLUSIONS: This study showed a similarly low rate of improvement or cure in children with persistent CSOM for both CIP and FGD topical therapies. Complications and side effects were insufficient to cease therapy or inform prescribing of either therapy.
Authors: Heidi C Smith-Vaughan; Anne B Chang; Derek S Sarovich; Robyn L Marsh; Keith Grimwood; Amanda J Leach; Peter S Morris; Erin P Price Journal: Clin Vaccine Immunol Date: 2013-11-27
Authors: Michael J Binks; Beth Temple; Lea-Ann Kirkham; Selma P Wiertsema; Eileen M Dunne; Peter C Richmond; Robyn L Marsh; Amanda J Leach; Heidi C Smith-Vaughan Journal: PLoS One Date: 2012-03-28 Impact factor: 3.240
Authors: Amanda Jane Leach; Edward Kim Mulholland; Mathu Santosham; Paul John Torzillo; Ngiare Joy Brown; Peter McIntyre; Heidi Smith-Vaughan; Sue Skull; Anne Balloch; Ross Andrews; Jonathan Carapetis; Joseph McDonnell; Vicki Krause; Peter Stanley Morris Journal: BMJ Open Date: 2015-01-16 Impact factor: 2.692
Authors: Robyn L Marsh; Michael J Binks; Jemima Beissbarth; Peter Christensen; Peter S Morris; Amanda J Leach; Heidi C Smith-Vaughan Journal: BMC Ear Nose Throat Disord Date: 2012-10-03
Authors: Christopher G Brennan-Jones; Karen Head; Lee-Yee Chong; Martin J Burton; Anne Gm Schilder; Mahmood F Bhutta Journal: Cochrane Database Syst Rev Date: 2020-01-02
Authors: Karen Head; Lee-Yee Chong; Mahmood F Bhutta; Peter S Morris; Shyan Vijayasekaran; Martin J Burton; Anne Gm Schilder; Christopher G Brennan-Jones Journal: Cochrane Database Syst Rev Date: 2020-01-06
Authors: Karen Head; Lee-Yee Chong; Mahmood F Bhutta; Peter S Morris; Shyan Vijayasekaran; Martin J Burton; Anne Gm Schilder; Christopher G Brennan-Jones Journal: Cochrane Database Syst Rev Date: 2020-01-06
Authors: Heidi C Smith-Vaughan; Michael J Binks; Robyn L Marsh; Mirjam Kaestli; Linda Ward; Kim M Hare; Susan J Pizzutto; Ruth B Thornton; Peter S Morris; Amanda J Leach Journal: BMC Ear Nose Throat Disord Date: 2013-10-08